(4-Amino-1-methylbutylamino)-6-methoxyquinoline, an inhibitor of protozoan growth,
presents an opportunity to explore nanostructured drug carriers to overcome these …

Malaria is a ubiquitous tropical disease which occurs by the bite of malaria parasite of genus
Plasmodium spp. The procurement and treatment of malaria depend on the cost and …

The occurrence of infectious parasitic disease is the leading driver of mortality worldwide.
Treatment of such parasitic disease is challenging due to the minimal target bioavailability of …

As an emerging novel drug carrier, nanoparticles provide a promising way for effective
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …

Malaria is a life-threatening parasitic disease transmitted by the infected female Anopheles
mosquito. The development of drug tolerance and challenges related to the drugs' …

Parasitic diseases remain a major public health problem, which affects hundreds of millions
of people especially in developing countries. Most of the available therapies for these …

Nanomedicine has emerged as a lucrative option, attracting the attention of scientific and
industrial stalwarts for its enormous potential and new business opportunities in the health …

Malaria is a life-threatening parasitic disease that affects millions of people worldwide,
especially in developing countries. Despite advances in conventional therapies, drug …

Malaria is arguably one of the main medical concerns worldwide because of the numbers of
people affected, the severity of the disease and the complexity of the life cycle of its …

Abstract................................................................................................. 449 15.1
Introduction................................................................................ 449 15.2 Overview of Neglected …